| Effect of Rapamycin in Ovarian Aging (NCT05836025) | Columbia University | 2023-06-01 |
| 12-week Study of NFX-179 Gel in Subjects With Epidermal Nevi (NCT05195762) | Albert Chiou | 2023-06-01 |
| Ultra-hypofractionated for Whole Breast Irradiation (WBI) Compared to Partial Breast Irradiation (PBI) (NCT05914831) | Oncology Institute of Vojvodina | 2023-06-01 |
| Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer (NCT05828381) | Fujian Medical University Union Hospital | 2023-06-01 |
| Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children (NCT06164600) | Ain Shams University | 2023-06-01 |
| Assessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous Adipose-derived REGEnerative Cells in the Local Treatment of Neuropathic Diabetic Foot ulcERs (NCT02866565) | Assistance Publique Hopitaux De Marseille | 2023-06-01 |
| IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssion (NCT06466278) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2023-06-01 |
| JS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung Cancer (NCT04951947) | Hunan Province Tumor Hospital | 2023-06-01 |
| A Clinical Trial of Fecal Microbiota Transplantation in a Population With Obsessive-compulsive Disorder (NCT05720793) | Valerie Taylor | 2023-06-01 |
| A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer (NCT06938711) | Context Therapeutics Inc. | 2023-06-01 |
| Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer (NCT05861271) | Fudan University | 2023-06-01 |
| Targeting Senescence to Reduce Osteoarthritis Pain and cartilagE Breakdown (ROPE) (NCT04770064) | Austin V Stone | 2023-06-01 |
| Sirolimus for Graves' Orbitopathy (GO) (NCT04598815) | University of Pisa | 2023-06-01 |
| Tislelizumab in Combination With Sitravatinib for Recurrent/Metastatic Cervical Cancer After Platinum-Based Chemotherapy (NCT05614453) | Australia New Zealand Gynaecological Oncology Group | 2023-06-01 |
| Scleral Buckling for Retinal Detachment Prevention in Genetically Confirmed Stickler Syndrome (NCT04465188) | Assistance Publique - Hôpitaux de Paris | 2023-06-01 |
| Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease (NCT06434792) | Hanlim Pharm. Co., Ltd. | 2023-06-01 |
| Evaluation of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans (NCT05876481) | Combat Stress | 2023-06-01 |
| Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial (NCT06114225) | Ruijin Hospital | 2023-06-01 |
| The Efficacy of L-Carnitine in the Management of Acute Clozapine Intoxication (NCT05632094) | Alexandria University | 2023-06-01 |
| De-escalation of Ticagrelor in Post PPCI (NCT05831462) | Assiut University | 2023-06-01 |
| Beta-glucans for Hospitalised Patients With COVID-19 (NCT05465798) | Wohlstand Pharmaceutical | 2023-06-01 |
| Nanodiamond-Gutta Percha Composite Biomaterials for Root Canal Therapy (NCT03376984) | University of California, Los Angeles | 2023-06-01 |
| A Study of CDX-0159 in Patients With Eosinophilic Esophagitis (NCT05774184) | Celldex Therapeutics | 2023-06-01 |
| Therapeutic Plasma Exchange in Septic Shock: A Pilot Study (NCT05093075) | University of Manitoba | 2023-06-01 |
| Study of Navtemadlin Plus Pembrolizumab as Maintenance Therapy in Locally Advanced and Metastatic Non-Small Cell Lung Cancer (NCT05705466) | Kartos Therapeutics, Inc. | 2023-06-01 |
| An Open, Single Center, Non-randomized, Single Arm Clinical Study of Evaluating the Efficacy of Selinexor in the Maintenance Treatment of PTCL (NCT05822050) | The First Hospital of Jilin University | 2023-06-01 |
| Gene Therapy With Modified Autologous Hematopoietic Stem Cells for Patients With Mucopolysaccharidosis Type II (NCT05665166) | University of Manchester | 2023-06-01 |
| Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer (NCT05766748) | Cantex Pharmaceuticals | 2023-06-01 |
| To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer. (NCT05859373) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-06-01 |
| Comparison Between Two Techniques During Thyroidectomy (Conventional Dissection Technique and Injection of Methylene Blue Dye Into Inferior Thyroid Artery Technique) Regarding Recurrent Laryngeal Nerve Identification and Preservation (NCT07067814) | Ain Shams University | 2023-06-01 |
| Rituximab Therapy in Patients With Treatment Refractory Hypersenstivity Pneumonitis (NCT07035561) | Shereen Medhat Mohammed Elsayed Nassar | 2023-06-01 |
| Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream (NCT05890703) | Juerg Hafner | 2023-06-01 |
| Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection (NCT06018363) | Dushu Lake Hospital Affiliated to Soochow University | 2023-06-01 |
| B7-H3 CAR-T for Recurrent or Refractory Glioblastoma (NCT04077866) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-06-01 |
| Intra-articular I-PRF Injections in Patients With Temporomandibular Joint Dysfunction (NCT05883982) | Hospital of the Ministry of Interior, Kielce, Poland | 2023-06-01 |
| H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis (NCT05872841) | Tianjin Medical University Cancer Institute and Hospital | 2023-06-01 |
| A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC (NCT05212922) | Eucure (Beijing) Biopharma Co., Ltd | 2023-06-01 |
| Low-dose IL-2 in Established T1D - The "PROREG" Study (NCT03243058) | Jay S. Skyler | 2023-06-01 |
| A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21) (NCT06295432) | Dizal Pharmaceuticals | 2023-06-01 |
| Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children (NCT05937191) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-06-01 |
| A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs (NCT06423170) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-06-01 |
| Prevalence of Humoral Dysfunction in Pts With Frequent Exacerbations of COPD, and the Effect of SCIgR for Prevention (NCT05764993) | Rochester General Hospital | 2023-06-01 |
| Exploratory Clinical Study of Neoadjuvant Immunotherapy Combined With Chemotherapy in Malignant Melanoma of Nasal and Paranasal Mucosa (NCT07614828) | Eye & ENT Hospital of Fudan University | 2023-06-01 |
| Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder (NCT05457465) | Mclean Hospital | 2023-06-01 |
| Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss. (NCT05786378) | Assiut University | 2023-06-01 |
| Radiological Evaluation of the Penis Before and After a Botox Injection (NCT06044883) | Cairo University | 2023-06-01 |
| A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors (NCT05864144) | Sensei Biotherapeutics, Inc. | 2023-05-31 |
| Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036) (NCT05714085) | Merck Sharp & Dohme LLC | 2023-05-31 |
| AT1001 for the Treatment of Long COVID (NCT05747534) | Massachusetts General Hospital | 2023-05-31 |
| A Study of HS-20094 in T2DM Participants (NCT06118008) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2023-05-31 |
| Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers (NCT05860296) | SignalChem Lifesciences Corporation | 2023-05-31 |
| Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer (NCT05908747) | Tianjin Medical University Cancer Institute and Hospital | 2023-05-31 |
| RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine (NCT05513560) | University Health Network, Toronto | 2023-05-31 |
| Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration (NCT05891548) | Clearside Biomedical, Inc. | 2023-05-31 |
| HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma (NCT05400902) | Binkui Li | 2023-05-31 |
| Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma (NCT05729646) | Yu jiren | 2023-05-31 |
| Safety and Efficacy of RHH646 for Knee Osteoarthritis (NCT05816395) | Novartis Pharmaceuticals | 2023-05-31 |
| Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial (NCT04941716) | Fred Hutchinson Cancer Center | 2023-05-31 |
| Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer (NCT05816655) | Korea University Guro Hospital | 2023-05-31 |
| A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer (NCT05496192) | Bristol-Myers Squibb | 2023-05-31 |
| PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer (NCT05518110) | Cancer Trials Ireland | 2023-05-31 |
| Effectiveness of Low-dose Naltrexone in Patients With Different Types of Vulvodynia (NCT05955313) | Medical University of Lublin | 2023-05-31 |
| A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) (NCT05824975) | GI Innovation, Inc. | 2023-05-30 |
| Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI (NCT04954599) | Maastricht University Medical Center | 2023-05-30 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat (NCT05736107) | Caliway Biopharmaceuticals Co., Ltd. | 2023-05-30 |
| Effectiveness of Topical Menthol as A Cooling Method During Exercise in A Recreational Runner Population (NCT07482046) | Taisho Pharmaceutical Indonesia | 2023-05-30 |
| Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO) (NCT05717062) | Ophirex, Inc. | 2023-05-30 |
| Duloxetine Impact on Postoperative Pain Control and Outcomes (NCT05611749) | Scripps Health | 2023-05-30 |
| A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD) (NCT06186804) | Abbisko Therapeutics Co, Ltd | 2023-05-30 |
| Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma (NCT05789303) | University of Chicago | 2023-05-30 |
| The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver Metastases (NCT05877001) | Peking University Cancer Hospital & Institute | 2023-05-30 |
| Venlafaxine for Postoperative Pain of Laparoscopic Cholecystectomy (NCT05884268) | Mansoura University | 2023-05-30 |
| Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma (NCT07644897) | Sun Yat-sen University | 2023-05-30 |
| An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder (NCT05674929) | Beckley Psytech Limited | 2023-05-30 |
| Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC (NCT05814666) | Flamingo Therapeutics NV | 2023-05-30 |
| A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV (NCT05904470) | Atea Pharmaceuticals, Inc. | 2023-05-30 |
| The Efficacy and Safety of a Chinese Herbal Medicine for Long COVID Associated Fatigue (NCT05684952) | Hong Kong Baptist University | 2023-05-30 |
| A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV (NCT05630885) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-05-30 |
| Dexmedetomidine for Intermittent Epidural Boluses Versus Continuous Epidural Infusion for Labour Epidural Analgesia (NCT05781854) | Assiut University | 2023-05-29 |
| Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas (NCT05809830) | Grupo Espanol de Investigacion en Sarcomas | 2023-05-29 |
| An Open-label Study That Will Test a Second Treatment Session of RZL-012. (NCT05763160) | Raziel Therapeutics Ltd. | 2023-05-29 |
| Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model. (NCT05933525) | Immuron Ltd. | 2023-05-29 |
| BCMA CAR-T Cell Therapy in High-risk NDMM Patients With Positive MRD After First-line ASCT (NCT05846737) | Institute of Hematology & Blood Diseases Hospital, China | 2023-05-29 |
| Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes (NCT05869812) | University of Kansas Medical Center | 2023-05-29 |
| Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis (NCT06183242) | POLYSAN Scientific & Technological Pharmaceutical Company | 2023-05-27 |
| Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer (NCT06496789) | Tianjin Medical University Cancer Institute and Hospital | 2023-05-27 |
| A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease (NCT05785624) | Genentech, Inc. | 2023-05-26 |
| A Study of MHB036C for Advanced Solid Tumor (NCT06373406) | Minghui Pharmaceutical (Hangzhou) Ltd | 2023-05-26 |
| Trial of Neoadjuvant Therapy With Paclitaxel and Carboplatin in Operable Locally Advanced Head and Neck Cancer Patients (NCT05294900) | Yonsei University | 2023-05-26 |
| NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing (NCT05825625) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2023-05-26 |
| A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy (NCT05590468) | Ralitza Gavrilova | 2023-05-26 |
| A Phase 2 Clinical Study of MIL62 in Systemic Lupus Erythematosus (NCT05796206) | Beijing Mabworks Biotech Co., Ltd. | 2023-05-26 |
| Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema (NCT05608837) | Quan Dong Nguyen | 2023-05-26 |
| Effect of Mesenchymal Stem Cells-derived Exosomes in Decompensated Liver Cirrhosis (NCT05871463) | Research Institute for Gastroenterology and Liver Diseases (RIGLD) | 2023-05-26 |
| TRPM8 in Acute Ischemic Stroke by Topical Menthol (NCT05877079) | Taipei Medical University Hospital | 2023-05-26 |
| Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors (NCT05732831) | Tango Therapeutics, Inc. | 2023-05-26 |
| Deep sequencIng in Cutaneous Squamous CEll caRciNomas (NCT05878288) | Peter MacCallum Cancer Centre, Australia | 2023-05-26 |
| Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma (NCT05834543) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-05-26 |
| Daratumumab in Primary Antiphospholipid Syndrome (NCT05671757) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-05-26 |
| The Pharmacological Effects of Using Cabozantinib With a Light Breakfast (NCT05263245) | dr. Tom van der Hulle | 2023-05-25 |